Highlights Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Market Closed - Nyse Other stock markets 04:00:02 2024-05-01 pm EDT			5-day change	1st Jan Change
84.3 ^USD	-0.44%		-4.86%	+10.56%

May. 01	Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	MT
Apr. 30	Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set	Apr. 25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q1 EPS $0.66, vs. Street Est of $0.64	Apr. 25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Reports Q1 Revenue $1.6B, vs. Street Est of $1.57B	Apr. 25	MT
Edwards Lifesciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Edwards Lifesciences Corporation Revises Earnings Guidance for the Full Year 2024	Apr. 25	CI
Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024	Apr. 25	CI
Edwards Lifesciences Announces the Release of Data from the Hudle Study	Apr. 07	CI
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	Mar. 21	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	Mar. 21	MT
Edwards Lifesciences Announces Large, Real-World Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	Mar. 11	CI
US FDA staff raises no new concerns about Abbott's heart device	Feb. 09	RE
Edwards Lifesciences beats quarterly estimates on strong heart device sales	Feb. 06	RE
Edwards Lifesciences' Q4 Adjusted Earnings Unchanged, Sales Rise; Q1, 2024 Guidance Set	Feb. 06	MT
Tranche Update on Edwards Lifesciences Corporation (NYSE:EW)'s Equity Buyback Plan announced on July 28, 2022.	Feb. 06	CI
Tranche Update on Edwards Lifesciences Corporation (NYSE:EW)'s Equity Buyback Plan announced on December 7, 2023.	Feb. 06	CI
Edwards Lifesciences Corporation Provides Earnings Guidance for the First Quarter and Full Year 2024	Feb. 06	CI
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q4 EPS $0.64, vs. Street Est of $0.64	Feb. 06	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q4 Revenue $1.53B, vs. Street Est of $1.5B	Feb. 06	MT
Edwards Lifesciences Guides For Q1 EPS of $0.62-$$0.66 on Sales of $1.53-$1.61 Billion, vs CIQ Analyst Consensus of $0.67/Share on Sales of $1.56 Billion	Feb. 06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT